Efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus inadequately controlled on the dual combination of metformin and sitagliptin: the VERTIS SITA2 trial

被引：0
|
作者：
Lauring, B. [1 ]
Eldor, R. [1 ]
Liu, J. [2 ]
Dagogo-Jack, S. [3 ]
Amorin, G. [4 ]
Johnson, J. [1 ]
Hille, D. [5 ]
Huyck, S. [1 ]
Golm, G. [1 ]
Terra, S. [6 ]
Mancuso, J. [7 ]
Engel, S. S. [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Chicago, IL USA
[3] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[4] MSD Argentina, Buenos Aires, DF, Argentina
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Pfizer Inc, Andover, MA USA
[7] Pfizer Inc, Groton, CT 06340 USA
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
181
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of ertugliflozin after 52 weeks in patients with type 2 diabetes inadequately controlled on metformin and sitagliptin: VERTIS SITA2 trial extension
    Eldor, R.
    Liu, J.
    Dagogo-Jack, S.
    Amorin, G.
    Johnson, J.
    Liao, Y.
    Huyck, S.
    Golm, G.
    Terra, S. G.
    Mancuso, J. P.
    Engel, S. S.
    Lauring, B.
    DIABETOLOGIA, 2017, 60 : S21 - S21
  • [2] Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study
    Dagogo-Jack, Samuel
    Liu, Jie
    Eldor, Roy
    Amorin, Guillermo
    Johnson, Jeremy
    Hille, Darcy
    Liao, Yuqin
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 530 - 540
  • [3] Safety and efficacy of ertugliflozin in combination with sitagliptin in patients with type 2 diabetes inadequately controlled on diet and exercise: the VERTIS SITA trial
    Lauring, B.
    Miller, S. S.
    Krumins, T.
    Zhou, H. J.
    Huyck, S.
    Johnson, J.
    Golm, G.
    Terra, S. G.
    Mancuso, J. P.
    Engel, S. S.
    DIABETOLOGIA, 2017, 60 : S407 - S408
  • [4] Safety and Efficacy of Ertugliflozin in Combination with Sitagliptin in Subjects with T2DM Inadequately Controlled on Diet and Exercise: The VERTIS SITA Trial
    Lauring, Brett
    Miller, Sam S.
    Krumins, Tania
    Zhou, Hao Jin
    Huyck, Susan
    Johnson, Jeremy
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    DIABETES, 2017, 66 : A319 - A320
  • [5] Safety and Efficacy of Ertugliflozin after 52 Weeks in Subjects with T2DM Inadequately Controlled on Metformin and Sitagliptin: Results from the Extension Phase of the VERTIS SITA2 Trial
    Liu, Jie
    Eldor, Roy
    Dagogo-Jack, Samuel
    Amorin, Guillermo
    Johnson, Jeremy
    Liao, Yuqin
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES, 2017, 66 : A35 - A35
  • [6] Safety and efficacy of ertugliflozin plus sitagliptin versus either treatment alone in subjects with type 2 diabetes inadequately controlled with metformin: the VERTIS FACTORIAL trial
    Pratley, R.
    Eldor, R.
    Golm, G.
    Huyck, S.
    Qiu, Y.
    Sunga, S.
    Johnson, J.
    Terra, S.
    Mancuso, J.
    Engel, S. S.
    Lauring, B.
    DIABETOLOGIA, 2016, 59 : S347 - S347
  • [7] Efficacy and safety of ertugliflozin in patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS MET trial
    Charbonnel, B.
    Pascu, R.
    Frias, J.
    Pall, D.
    Saur, D.
    Darekar, A.
    Huyck, S.
    Shi, H.
    Lauring, B.
    Terra, S.
    Rosenstock, J.
    DIABETOLOGIA, 2017, 60 : S406 - S407
  • [8] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
    Ji, Linong
    Liu, Yanmei
    Miao, Heng
    Xie, Yongli
    Yang, Ming
    Wang, Wei
    Mu, Yuting
    Yan, Ping
    Pan, Sharon
    Lauring, Brett
    Liu, Shu
    Huyck, Susan
    Qiu, Yanping
    Terra, Steven G.
    DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1474 - 1482
  • [9] Safety and efficacy of ertugliflozin compared to glimepiride in patients with type 2 diabetes inadequately controlled on metformin: the VERTIS SU trial
    Hollander, P.
    Liu, J.
    Hill, J.
    Johnson, J.
    Jiang, Z.
    Golm, G.
    Huyck, S.
    Terra, S.
    Mancuso, J. P.
    Engel, S.
    Lauring, B.
    DIABETOLOGIA, 2017, 60 : S19 - S20
  • [10] Safety and efficacy of Ertugliflozin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy in the VERTIS-Asia study
    Yang, Ming
    Ji, Linong
    Liu, Yanmei
    Miao, Heng
    Xie, Yongli
    Wang, Wei
    Mu, Yuting
    Yan, Ping
    Pan, Sharon
    Lauring, Brett
    Liu, Shu
    Huyck, Susan
    Wang, Yinna
    Terra, Steven G.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
12345